This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown,...
Audience: Consumer, Health Professional, Pharmacy February 13, 2025 LAKE FOREST,...
Audience: Consumer Natural Dior LLC (USA) – February 25, 2025 – Natural ...
Audience: Pharmacy, Health Care Professional February 24, 2025 – Bethlehem, PA. ...
Audience: Consumer, Pharmacy March 11, 2025 -- FDA is alerting the public and in...
Audience: Patient, Health Professional, Pharmacy, Immunology March 10, 2025 -- A...
Audience: Consumer Benton, Arkansas – 03/03/2025 –One Source Nutrition is volunt...
Audience: Pharmacy, Health Care Professional March 13, 2025 -- Dr. Reddy’s Labor...
Audience: Consumer, Health Professional, Pulmonology March 14, 2025 -- FDA advis...
Audience: Consumers April 14, 2025 -- FDA was notified by Novo Nordisk on April ...
Audience: Consumer, Health Professional, Pharmacy April 18, 2025 -- Bridgewater,...
Audience: Health Care Providers, Compounders, Consumers April 22, 2025 -- FDA ha...
April 3, 2025 -- An artificial intelligence (AI)-driven screening tool, develope...
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) ...
April 1, 2025 -- A new form of tumor infiltrating lymphocyte (TIL) therapy, a fo...
South San Francisco, CA -- April 3, 2025 -- Genentech, a member of the Roche Gro...
SAN CARLOS, Calif.--(BUSINESS WIRE) April 3, 2025 -- BeiGene, Ltd. (NASDAQ: ONC;...
Paris, April 3, 2025. The US Food and Drug Administration (FDA) has granted orph...
San Diego, CA, USA, Berlin, Germany, April 3, 2025 – Vividion Therapeutics, Inc....
SPRING HOUSE, Pa. (April 10, 2025) – Johnson & Johnson (NYSE: JNJ) today announc...
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Allogene Therape...
DUBLIN, April 7, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Bi...
HOUSTON, April 14, 2025 /PRNewswire/ -- Cellenkos Inc., a clinical-stage biotech...
BOSTON, April 11, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage ...